Risultati per: Transgender – Competenze e ruoli del medico di medicina generale

Entrata in funzione al reparto di oncoematologia di Rimini

Entrata in funzione al reparto di oncoematologia di Rimini

Il secondo step sarà lavorare sull’accesso alle specializzazioni

In corsa quasi 80mila candidati per 14.787 posti, numeri in linea con l’anno scorso che però potrebbero salire nei prossimi mesi a 18-19mila.

Già da quest’anno +20-30% iscrivibili.Vera carenza su infermieri

Già da quest’anno +20-30% iscrivibili.Vera carenza su infermieri

Rocca, particolarmente contento di eccellenza a Civitavecchia

Il ministro della Salute Schillaci annuncia di voler depenalizzare la responsabilità medica, tranne che per il dolo, e mantenendo solo quella civile

Al via i nuovi incentivi contenuti nel decreto bollette appena approdato sulla Gazzetta Ufficiale per provare a trattenere medici e infermieri nella trincea del pronto soccorso

This narrative review examines primary and secondary prevention of cancer, barriers to health care services, and health care practitioners’ knowledge about specific issues pertaining to transgender and gender-diverse individuals.

Con lui sempre l’infermiere di fiducia. I medici e le cure

Inaugurazione a Castelplanio l’1 aprile con Ghebreyesus

Introduction
The effect of testosterone (T) therapy on the vaginal microbiota of transgender men (TGM) is not well characterised, although one cross-sectional study comparing the vaginal microbiota of cisgender women to TGM on T≥1 year found that, in 71% of the TGM, the vaginal microbiota was less likely to be Lactobacillus-dominated and more likely to be enriched with >30 other bacterial species, many associated with bacterial vaginosis (BV). This prospective study aims to investigate changes in the composition of the vaginal microbiota over time in TGM who retain their natal genitalia (ie, vagina) and initiate T. In addition, we will identify changes in the vaginal microbiota preceding incident BV (iBV) in this cohort while investigating behavioural factors, along with hormonal shifts, which may be associated with iBV.

Methods and analysis
T-naïve TGM who have not undergone gender-affirming genital surgery with normal baseline vaginal microbiota (ie, no Amsel criteria, normal Nugent Score with no Gardnerella vaginalis morphotypes) will self-collect daily vaginal specimens for 7 days prior to initiating T and for 90 days thereafter. These specimens will be used for vaginal Gram stain, 16S rRNA gene sequencing and shotgun metagenomic sequencing to characterise shifts in the vaginal microbiota over time, including development of iBV. Participants will complete daily diaries on douching, menses and behavioural factors including sexual activity during the study.

Ethics and dissemination
This protocol is approved through the single Institutional Review Board mechanism by the University of Alabama at Birmingham. External relying sites are the Louisiana State University Health Sciences Center, New Orleans Human Research Protection Program and the Indiana University Human Research Protection Program. Study findings will be presented at scientific conferences and peer-reviewed journals as well as shared with community advisory boards at participating gender health clinics and community-based organisations servicing transgender people.

Registration details
Protocol # IRB-300008073.

Per diagnosi e terapia alcune forme tumore, sclerosi e diabete

Diventano dodici le Regioni dove non è più chiesto. Anche i medici d’accordo perché la maggior parte delle malattie infettive non si trasmettono durante la convalescenza